In vitro synergistic effects of double combinations of β-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae

Journal of Infection and Chemotherapy

Volumn 12, Issue 4, 2006, Pages 172-176

  Furuya, Ryusaburo ^a   Nakayama, Hiroshi ^b   Kanayama, Akiko ^c   Saika, Takeshi ^c   Iyoda, Takako ^c   Tatewaki, Mitsuhiro ^c   Matsuzaki, Kaoru ^c   Kobayashi, Intetsu ^c   Tanaka, Masatoshi ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nakayama Urologic Clinic   (Japan)

^c LSI MEDIENCE CORPORATION   (Japan)

Author keywords

Azithromycin; Neisseria gonorrhoeae; Synergy; Lactam

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BETA LACTAM; CEFIXIME; CEFTERAM;

ARTICLE; BACTERIUM ISOLATE; DRUG MECHANISM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE;

EID: 33748302315     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-006-0445-z     Document Type: Article

References (14)

1. M Tanaka H Nakayama M Haraoka T Saika I Kobayashi S Naito 2000 Antimicrobial resistance of Neisseria gonorrhoeae and high prevalence of ciprofloxacin-resistant isolates in Japan, 1993 to 1998 J Clin Microbiol 38 521 5
2. M Tanaka H Nakayama T Notomi S Irie Y Tsunoda A Okadome 2004 Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993 to 2002: continuous increasing of ciprofloxacin-resistant isolates Int J Antimicrob Agents 24S S15 S22
3. S Kamidono T Matsumoto 2004 Gonococcal infections, 2004 guidelines for diagnosis and treatment for sexually transmitted diseases Jpn J STD 15 Suppl 8 13
4. Centers for Disease Control and Prevention 2002 Sexually transmitted diseases treatment guidelines 2002 Morb Mortal Wkly Rep 51 RR-6 36 42
5. M Tanaka J Kumazawa T Matsumoto Y Kumamoto T Hirose T Saka 1996 Basic and clinical studies of azithromycin for the treatment of sexually transmitted male urethritis Jpn Arch STD 7 76 91
6. Clinical and Laboratory Standards Institute 2005 Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement CLSI document M100-S15 CLSI Wayne, PA
7. GM Eliopoulos RC Moellering 1996 Antimicrobial combinations V Lorian Antibiotics in laboratory medicine 4th ed Williams and Wilkins Baltimore, MD 330 96
8. Tanaka M, Huruya R, Nakayama H, Iyota T, Saika T, Kobayashi I. Antimicrobial resistance of Neisseria gonorrhoeae in Fukuoka city, Japan 2004. Jpn J STD 2005; A-02, 49
9. MW Ruble DH Gilbert SH Zinner 1995 In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria Clin Microbiol Infect 1 183 9
10. F Fernandez-Cuenca L Martinez-Martinez A Pascual EJ Perea 2003 In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii Chemotherapy 49 24 6
11. SJ Martin SL Pendland C Chen P Schreckenberger LH Danziger 1996 In vitro synergy testing of macrolide-quinolone combinations against 41 clinical isolates of Legionella Antimicrob Agents Chemother 40 1419 21
12. DH Martin TF Mroczkowski ZA Dalu J [tmp] McCarty RB Jones SJ Hopkins 1992 A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group N Engl J Med 327 921 5
13. A Nilsen A Halsos A Johansen E Hansen E Torud D Moseng 1992 A double blind study of single dose azithromycin and doxycycline in the treatment of chlamydial urethritis in males Genitourin Med 68 325 7
14. EM Thorpe Jr WE Stamm EW Hook 3rd SA Gall RB Jones K Henry 1996 Chlamydial cervicitis and urethritis: single dose treatment compared with doxycycline for 7 days in community based practises Genitourin Med 72 93 7